Vyepti (eptinezumab) is a monoclonal antibody medication that is FDA approved for prevention of Chronic Migraine (14 or more headache days a month). It blocks a protein in the brain called CGRP, which is thought to be a cause of Migraine attacks. The medication is administered by IV in a clinic setting. I’ve been receiving […]